Levin M, Pras M, Franklin E C
J Exp Med. 1973 Aug 1;138(2):373-80. doi: 10.1084/jem.138.2.373.
Antisera have been prepared against the major nonimmunoglobulin component of secondary and familial Mediterranean fever (FMF) associated amyloid which has been called A component or acid soluble fraction (ASF). The antisera were shown to be monospecific for ASF by precipitation of (125)I-labeled antigen and gave a reaction of identity with four different ASF preparations. The antisera were able to detect a circulating component in human serum that migrated in the alpha1-globulin region. This circulating component gave a line of identity with degraded ASF by double immunodiffusion. 57 normal sera and 89 sera from patients with diseases known to be frequently associated with amyloidosis were tested by immunodiffusion for the circulating ASF component. 7% of normal sera and 50-80% of the pathologic sera had elevated amounts of this component. Absorption studies showed that all normal sera probably have small amounts of this component while cord sera do not have detectable amounts. This component was partially purified and was shown to be slightly larger than albumin. The relation of the circulating component to the acid soluble fraction of amyloid is discussed.
已制备出针对继发性和家族性地中海热(FMF)相关淀粉样蛋白主要非免疫球蛋白成分的抗血清,该成分被称为A成分或酸溶性部分(ASF)。通过对(125)I标记抗原的沉淀表明,这些抗血清对ASF具有单特异性,并与四种不同的ASF制剂产生同一性反应。这些抗血清能够检测到人血清中在α1球蛋白区域迁移的循环成分。通过双向免疫扩散,这种循环成分与降解的ASF产生一条同一性沉淀线。对57份正常血清和89份已知经常与淀粉样变性相关疾病患者的血清进行免疫扩散检测循环ASF成分。7%的正常血清和50 - 80%的病理血清中该成分含量升高。吸收研究表明,所有正常血清可能都含有少量该成分,而脐带血清中未检测到该成分。该成分经过部分纯化,显示其略大于白蛋白。本文讨论了循环成分与淀粉样蛋白酸溶性部分的关系。